Tags

Type your tag names separated by a space and hit enter

HPV vaccine acceptability in high-risk Greek men.
Hum Vaccin Immunother. 2018 01 02; 14(1):134-139.HV

Abstract

HPV is associated with malignancy in men, yet there is a lack of data on HPV knowledge, vaccine acceptability, and factors affecting vaccine acceptability in Greek men. This study aims to identify determinants of knowledge and willingness to vaccinate against HPV among high-risk Greek men. Men (n = 298) between the ages of 18 and 55 were enrolled from the STI and HIV clinics at "Andreas Syggros" Hospital in Athens, Greece from July-October 2015. Participants completed a survey on demographics, economic factors, sexual history, HPV knowledge, and vaccine acceptability. The majority of participants were younger than 40 (76.6%) and unmarried (84.6%). Our sample was 31.2% MSM (men who have sex with men), and 20.1% were HIV-positive. Most participants (>90%) were aware that HPV is highly prevalent in both men and women; however, fewer identified that HPV causes cancers in both sexes (68%) and that vaccination protects men and women (67%). Amongst participants, 76.7% were willing to vaccinate themselves against HPV, 71.4% an adolescent son, and 69.3% an adolescent daughter. HIV-positive men were more likely to be willing to vaccinate themselves (OR 2.83, p = .015), a son (OR 3.3, p = .015) or a daughter (3.01, p = .020). Higher income levels were associated with increased willingness to vaccinate oneself (OR 1.32, p = .027), a son (1.33, p = .032) or daughter (1.34, p = .027). Although there is a HPV knowledge gap, HPV vaccine acceptability is high despite lack of vaccine promotion to Greek men. Future studies should include lower-risk men to adequately inform public health efforts.

Authors+Show Affiliations

a Biological Sciences Division , University of Chicago Pritzker School of Medicine , Chicago , USA.a Biological Sciences Division , University of Chicago Pritzker School of Medicine , Chicago , USA.b 1st Department of Dermatology and Venereology , National and Kapodistrian University of Athens School of Medicine, "Andreas Syggros" Hospital , Athens , Greece.b 1st Department of Dermatology and Venereology , National and Kapodistrian University of Athens School of Medicine, "Andreas Syggros" Hospital , Athens , Greece.b 1st Department of Dermatology and Venereology , National and Kapodistrian University of Athens School of Medicine, "Andreas Syggros" Hospital , Athens , Greece.b 1st Department of Dermatology and Venereology , National and Kapodistrian University of Athens School of Medicine, "Andreas Syggros" Hospital , Athens , Greece.b 1st Department of Dermatology and Venereology , National and Kapodistrian University of Athens School of Medicine, "Andreas Syggros" Hospital , Athens , Greece.c National and Kapodistrian University of Athens School of Medicine , Athens , Greece.c National and Kapodistrian University of Athens School of Medicine , Athens , Greece.d University of Chicago Medicine , Department of Medicine , Chicago , USA. e University of Chicago, Medicine , Department of Public Health Sciences , Chicago , USA.f University of Chicago Medicine , Department of Pathology , Chicago , USA.

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

28937851

Citation

Hoefer, Lea, et al. "HPV Vaccine Acceptability in High-risk Greek Men." Human Vaccines & Immunotherapeutics, vol. 14, no. 1, 2018, pp. 134-139.
Hoefer L, Tsikis S, Bethimoutis G, et al. HPV vaccine acceptability in high-risk Greek men. Hum Vaccin Immunother. 2018;14(1):134-139.
Hoefer, L., Tsikis, S., Bethimoutis, G., Nicolaidou, E., Paparizos, V., Antoniou, C., Kanelleas, A., Chardalias, L., Stavropoulos, G. E., Schneider, J., & Charnot-Katsikas, A. (2018). HPV vaccine acceptability in high-risk Greek men. Human Vaccines & Immunotherapeutics, 14(1), 134-139. https://doi.org/10.1080/21645515.2017.1379640
Hoefer L, et al. HPV Vaccine Acceptability in High-risk Greek Men. Hum Vaccin Immunother. 2018 01 2;14(1):134-139. PubMed PMID: 28937851.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - HPV vaccine acceptability in high-risk Greek men. AU - Hoefer,Lea, AU - Tsikis,Savas, AU - Bethimoutis,George, AU - Nicolaidou,Electra, AU - Paparizos,Vassilios, AU - Antoniou,Christina, AU - Kanelleas,Antonios, AU - Chardalias,Leonidas, AU - Stavropoulos,Georgios-Emmanouil, AU - Schneider,John, AU - Charnot-Katsikas,Angella, Y1 - 2017/10/24/ PY - 2017/9/25/pubmed PY - 2019/1/12/medline PY - 2017/9/23/entrez KW - Attitudes KW - HPV KW - Men KW - Patients-views KW - Vaccination SP - 134 EP - 139 JF - Human vaccines & immunotherapeutics JO - Hum Vaccin Immunother VL - 14 IS - 1 N2 - HPV is associated with malignancy in men, yet there is a lack of data on HPV knowledge, vaccine acceptability, and factors affecting vaccine acceptability in Greek men. This study aims to identify determinants of knowledge and willingness to vaccinate against HPV among high-risk Greek men. Men (n = 298) between the ages of 18 and 55 were enrolled from the STI and HIV clinics at "Andreas Syggros" Hospital in Athens, Greece from July-October 2015. Participants completed a survey on demographics, economic factors, sexual history, HPV knowledge, and vaccine acceptability. The majority of participants were younger than 40 (76.6%) and unmarried (84.6%). Our sample was 31.2% MSM (men who have sex with men), and 20.1% were HIV-positive. Most participants (>90%) were aware that HPV is highly prevalent in both men and women; however, fewer identified that HPV causes cancers in both sexes (68%) and that vaccination protects men and women (67%). Amongst participants, 76.7% were willing to vaccinate themselves against HPV, 71.4% an adolescent son, and 69.3% an adolescent daughter. HIV-positive men were more likely to be willing to vaccinate themselves (OR 2.83, p = .015), a son (OR 3.3, p = .015) or a daughter (3.01, p = .020). Higher income levels were associated with increased willingness to vaccinate oneself (OR 1.32, p = .027), a son (1.33, p = .032) or daughter (1.34, p = .027). Although there is a HPV knowledge gap, HPV vaccine acceptability is high despite lack of vaccine promotion to Greek men. Future studies should include lower-risk men to adequately inform public health efforts. SN - 2164-554X UR - https://www.unboundmedicine.com/medline/citation/28937851/HPV_vaccine_acceptability_in_high_risk_Greek_men_ L2 - https://www.tandfonline.com/doi/full/10.1080/21645515.2017.1379640 DB - PRIME DP - Unbound Medicine ER -